- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging EZH2 Inhibitors and Their Application in Lymphoma
Authors
Keywords
EZH2, Epigenetics, Non-Hodgkin lymphoma, EZH2 inhibitors, Histone methylation
Journal
Current Hematologic Malignancy Reports
Volume 13, Issue 5, Pages 369-382
Publisher
Springer Nature America, Inc
Online
2018-08-15
DOI
10.1007/s11899-018-0466-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 42OA phase 1 study of CPI-1205, a small molecule inhibitor of EZH2, preliminary safety in patients with B-cell lymphomas
- (2018) W Harb et al. ANNALS OF ONCOLOGY
- Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
- (2018) Roland Schmitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- ORAL AZACYTIDINE (AZA) AND ROMIDEPSIN (R) REVEALS PROMISING ACTIVITY IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) PERIPHERAL T-CELL LYMPHOMA (PTCL)
- (2017) O.A. O'Connor et al. HEMATOLOGICAL ONCOLOGY
- INTERIM REPORT FROM A PHASE 2 MULTICENTER STUDY OF TAZEMETOSTAT, AN EZH2 INHIBITOR, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMAS
- (2017) F. Morschhauser et al. HEMATOLOGICAL ONCOLOGY
- The roles of Polycomb group proteins in hematopoietic stem cells and hematological malignancies
- (2016) Emi Takamatsu-Ichihara et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Identification of (R)-N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for Phase I Clinical Trials for B-Cell Lymphomas
- (2016) Rishi G. Vaswani et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
- (2016) Andrew W. Roberts et al. NEW ENGLAND JOURNAL OF MEDICINE
- S-Adenosyl-L-methionine-competitive inhibitors of the histone methyltransferase EZH2 induce autophagy and enhance drug sensitivity in cancer cells
- (2015) Tsang-Pai Liu et al. ANTI-CANCER DRUGS
- Deregulation of DNMT1, DNMT3B and miR-29s in Burkitt lymphoma suggests novel contribution for disease pathogenesis
- (2015) Marcela C. Robaina et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors
- (2015) Daniel Zingg et al. Nature Communications
- Reaction Coupling between Wild-Type and Disease-Associated Mutant EZH2
- (2014) Brooke M. Swalm et al. ACS Chemical Biology
- A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesis
- (2014) T. Berg et al. BLOOD
- Selective inhibition of EZH2 and EZH1 enzymatic activity by a small molecule suppresses MLL-rearranged leukemia
- (2014) B. Xu et al. BLOOD
- EZH2: Not EZHY (Easy) to Deal
- (2014) Gauri Deb et al. MOLECULAR CANCER RESEARCH
- Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma
- (2014) S. K. Knutson et al. MOLECULAR CANCER THERAPEUTICS
- A687V EZH2 Is a Driver of Histone H3 Lysine 27 (H3K27) Hypertrimethylation
- (2014) H. M. Ott et al. MOLECULAR CANCER THERAPEUTICS
- Oncogenic Y641 mutations in EZH2 prevent Jak2/β-TrCP-mediated degradation
- (2014) A A Sahasrabuddhe et al. ONCOGENE
- An Orally Bioavailable Chemical Probe of the Lysine Methyltransferases EZH2 and EZH1
- (2013) Kyle D. Konze et al. ACS Chemical Biology
- Sirtuin and pan-class I/II deacetylase (DAC) inhibition is synergistic in preclinical models and clinical studies of lymphoma
- (2013) J. E. Amengual et al. BLOOD
- EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity
- (2013) J. Yan et al. BLOOD
- EZH2 mutations are frequent and represent an early event in follicular lymphoma
- (2013) C. Bodor et al. BLOOD
- EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation
- (2013) Wendy Béguelin et al. CANCER CELL
- Role of microRNA in the pathogenesis of malignant lymphoma
- (2013) Hiroyuki Tagawa et al. CANCER SCIENCE
- Identification of EZH2 and EZH1 Small Molecule Inhibitors with Selective Impact on Diffuse Large B Cell Lymphoma Cell Growth
- (2013) Shivani Garapaty-Rao et al. CHEMISTRY & BIOLOGY
- Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis
- (2013) Marieta Caganova et al. JOURNAL OF CLINICAL INVESTIGATION
- Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies
- (2013) S N Khan et al. LEUKEMIA
- NF-YA Underlies EZH2 Upregulation and Is Essential for Proliferation of Human Epithelial Ovarian Cancer Cells
- (2013) Azat Garipov et al. MOLECULAR CANCER RESEARCH
- Transcriptional regulation by Polycomb group proteins
- (2013) Luciano Di Croce et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Correction: Utility of NT-proBNP for Identifying LV Failure in Patients with Acute Exacerbation of Chronic Bronchitis
- (2013) Qing-ping Wang et al. PLoS One
- Genomic Deregulation of the E2F/Rb Pathway Leads to Activation of the Oncogene EZH2 in Small Cell Lung Cancer
- (2013) Bradley P. Coe et al. PLoS One
- Mechanism-Based Epigenetic Chemosensitization Therapy of Diffuse Large B-Cell Lymphoma
- (2013) T. Clozel et al. Cancer Discovery
- Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia
- (2012) S. Tanaka et al. BLOOD
- Coordinated Silencing of MYC-Mediated miR-29 by HDAC3 and EZH2 as a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas
- (2012) Xinwei Zhang et al. CANCER CELL
- MYC Acts via the PTEN Tumor Suppressor to Elicit Autoregulation and Genome-Wide Gene Repression by Activation of the Ezh2 Methyltransferase
- (2012) M. Kaur et al. CANCER RESEARCH
- RYBP-PRC1 Complexes Mediate H2A Ubiquitylation at Polycomb Target Sites Independently of PRC2 and H3K27me3
- (2012) Lígia Tavares et al. CELL
- Superior Efficacy of a Combined Epigenetic Therapy against Human Mantle Cell Lymphoma Cells
- (2012) W. Fiskus et al. CLINICAL CANCER RESEARCH
- A687V EZH2 is a gain-of-function mutation found in lymphoma patients
- (2012) Christina R. Majer et al. FEBS LETTERS
- EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
- (2012) Michael T. McCabe et al. NATURE
- A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells
- (2012) Sarah K Knutson et al. Nature Chemical Biology
- The genetic landscape of mutations in Burkitt lymphoma
- (2012) Cassandra Love et al. NATURE GENETICS
- Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia
- (2012) Panagiotis Ntziachristos et al. NATURE MEDICINE
- Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27)
- (2012) M. T. McCabe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation
- (2012) W. Qi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent
- (2012) K. Xu et al. SCIENCE
- Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2
- (2012) Sharad K. Verma et al. ACS Medicinal Chemistry Letters
- Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A
- (2011) A. M. Jankowska et al. BLOOD
- EZH2 mutational status predicts poor survival in myelofibrosis
- (2011) P. Guglielmelli et al. BLOOD
- HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL
- (2011) M. Kalac et al. BLOOD
- EZH2 Promotes Expansion of Breast Tumor Initiating Cells through Activation of RAF1-β-Catenin Signaling
- (2011) Chun-Ju Chang et al. CANCER CELL
- Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma
- (2011) Tung Nguyen et al. Epigenetics
- Overexpression of enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia/lymphoma as a target for epigenetic therapy
- (2011) D. Sasaki et al. HAEMATOLOGICA
- EZH2 Y641 mutations in follicular lymphoma
- (2011) C Bödör et al. LEUKEMIA
- Context-Specific Regulation of NF-κB Target Gene Expression by EZH2 in Breast Cancers
- (2011) Shuet Theng Lee et al. MOLECULAR CELL
- Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
- (2011) Ryan D. Morin et al. NATURE
- The Polycomb complex PRC2 and its mark in life
- (2011) Raphaël Margueron et al. NATURE
- MEK–ERK pathway regulates EZH2 overexpression in association with aggressive breast cancer subtypes
- (2011) S Fujii et al. ONCOGENE
- EZH2 Codon 641 Mutations are Common in BCL2-Rearranged Germinal Center B Cell Lymphomas
- (2011) Russell J. H. Ryan et al. PLoS One
- Global Gene Expression Analysis of Very Small Embryonic-Like Stem Cells Reveals that the Ezh2-Dependent Bivalent Domain Mechanism Contributes to Their Pluripotent State
- (2011) Dong-Myung Shin et al. STEM CELLS AND DEVELOPMENT
- EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis
- (2010) I. Velichutina et al. BLOOD
- Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
- (2010) Nina Wagener et al. BMC CANCER
- MiRNA profiling in B non-Hodgkin lymphoma: a MYC-related miRNA profile characterizes Burkitt lymphoma
- (2010) Jan-Lukas Robertus et al. BRITISH JOURNAL OF HAEMATOLOGY
- Notch signalling in T-cell lymphoblastic leukaemia/lymphoma and other haematological malignancies
- (2010) Jon C Aster et al. JOURNAL OF PATHOLOGY
- Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling
- (2010) Siok-Bian Ng et al. JOURNAL OF PATHOLOGY
- Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint
- (2010) Han Liu et al. NATURE
- Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes
- (2010) Gorica Nikoloski et al. NATURE GENETICS
- Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
- (2010) Ryan D Morin et al. NATURE GENETICS
- Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
- (2010) Thomas Ernst et al. NATURE GENETICS
- Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas
- (2010) C. J. Sneeringer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells
- (2009) W. Fiskus et al. BLOOD
- MicroRNA 29b functions in acute myeloid leukemia
- (2009) R. Garzon et al. BLOOD
- Chromatin Signatures in Multipotent Human Hematopoietic Stem Cells Indicate the Fate of Bivalent Genes during Differentiation
- (2009) Kairong Cui et al. Cell Stem Cell
- Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma
- (2009) S Eckerle et al. LEUKEMIA
- DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation
- (2009) T. B. Miranda et al. MOLECULAR CANCER THERAPEUTICS
- Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells
- (2008) Hideo Watanabe et al. Cancer Cell International
- Ezh1 and Ezh2 Maintain Repressive Chromatin through Different Mechanisms
- (2008) Raphael Margueron et al. MOLECULAR CELL
- EZH1 Mediates Methylation on Histone H3 Lysine 27 and Complements EZH2 in Maintaining Stem Cell Identity and Executing Pluripotency
- (2008) Xiaohua Shen et al. MOLECULAR CELL
- miR-29 miRNAs activate p53 by targeting p85α and CDC42
- (2008) Seong-Yeon Park et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer
- (2008) S. Varambally et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started